Excessive undesired bleeding can create difficulties during surgery, from obscuring the operative field of view to creating haematomas and if severe enough, can endanger a patient’s life. Haemostatic products are specifically designed to staunch bleeding and play an essential role in a range of surgical settings.
Having the right product at hand at the right moment can help improve patient outcomes, streamline surgical procedures, and prevent unnecessary delays.
The Okcel product range, manufactured by chemical experts Synthesia in the Czech Republic, is made up of four types of oxidised cellulose haemostats that have been developed for a variety of specialist uses. The product’s unique formulation provides a tailored solution for different situations, from laparoscopic procedures to major surgery. Effective and efficient, Okcel contributes to enhanced patient recovery and gives surgeons a product they can rely on.
Okcel is exceptionally absorbent when compared to traditional haemostats due to factors such as its higher area density. This allows it to act quickly to control bleeding and keep operations running smoothly. Designed for speed and precision, the product has established a new standard in haemostasis and operational effectiveness.
The application of Okcel generates haemostasis within minutes, far quicker than other oxidised cellulose products on the market. Using haemostatic agents in surgery is important as it significantly boosts the body's capacity to staunch bleeding and protects critical tissues. By acting fast, Okcel helps to minimise disruptions to operations and streamline the surgical workflow.
This innovative product offers surgeons two key advantages: reduced costs and better patient care. Okcel’s ability to address haemorrhagic challenges swiftly and effectively contributes directly to improved patient outcomes, while its affordability can deliver substantial cost savings for healthcare institutions.
In 2014, a major cardiac NHS Foundation Trust switched from the market-leading haemostat to Okcel. As a result, it saved an incredible £350,000 over four years and continues to save around £90,000 per year, all while maintaining high standards of patient care.
No matter the operation, surgeons need to know they are using a haemostat they can rely on. Okcel’s fast, consistent, and precise haemostatic action leads to fewer interruptions to operations and means medical professionals can get on with the job at hand. By allowing surgeons to focus on their craft, Okcel helps hospitals provide better care, improved patient outcomes, and higher levels of patient satisfaction.
Enhance the safety and efficiency of your surgeries, optimise resource allocation, and witness the positive impact on patient satisfaction and your bottom line. Get in touch with Uniplex today to find out more!